Your browser doesn't support javascript.
loading
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
Jacobson, Ira M; Bourgeois, Stefan; Mathurin, Phillipe; Thuluvath, Paul; Ryder, Stephen D; Gerken, Guido; Hernandez, Candido; Vanstraelen, Kim; Scherbakovsky, Stacey; Osinusi, Anu; Tedesco, Dana; Foster, Graham R.
Affiliation
  • Jacobson IM; NYU Langone Health, New York, New York, USA.
  • Bourgeois S; Campus Stuivenberg, Antwerp, Belgium.
  • Mathurin P; Centre Hospitalier Universitaire de Lille, Universite Nord de France, Lille, France.
  • Thuluvath P; Institute for Digestive Health and Liver Disease, Baltimore, Maryland, USA.
  • Ryder SD; NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust and The University of Nottingham, Queen's Medical Centre Campus, Nottingham, UK.
  • Gerken G; Helios Klinikum Niederberg, Velbert, Germany.
  • Hernandez C; Gilead Sciences Europe LTD, Uxbridge, UK.
  • Vanstraelen K; Gilead Sciences Europe LTD, Uxbridge, UK.
  • Scherbakovsky S; Gilead Sciences, Inc, Foster City, California, USA.
  • Osinusi A; Gilead Sciences, Inc, Foster City, California, USA.
  • Tedesco D; Gilead Sciences, Inc, Foster City, California, USA.
  • Foster GR; Queen Mary University, London, UK.
J Viral Hepat ; 30(5): 448-454, 2023 05.
Article in En | MEDLINE | ID: mdl-36740893

Full text: 1 Database: MEDLINE Main subject: Hepatitis C / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Hepatitis C / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Humans Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2023 Type: Article Affiliation country: United States